期刊文献+

骨髓间充质干细胞移植治疗小鼠内毒素血症的实验研究 被引量:1

Effects of bone marrow mesenchymal stem cell therapy on mice with endotoxemia
原文传递
导出
摘要 目的:明确骨髓间充质干细胞(MSCs)对内毒素血症小鼠的治疗作用。方法:动物分为4组:对照组、内毒素血症组、间充质干细胞治疗组、间充质干细胞组。分别在内毒素脂多糖(LPS)注射24 h和7 d后观察小鼠心功能的变化,ELISA方法检测血清细胞因子的水平,组织学方法观察对心肌、肝脏、肺脏和肾脏形态学改变的影响。结果:与对照组小鼠相比,内毒素血症组经LPS刺激后血清白介素1β(IL-1β)和肿瘤坏死因子α(TNF-α)含量增高,间充质干细胞治疗组血清IL-1β和TNF-α含量明显降低;内毒素血症组小鼠心功能明显下降,间充质干细胞治疗组心功能明显恢复;内毒素血症小鼠心肌细胞和肝细胞凋亡增加,肺间质和肺泡水肿,间充质干细胞治疗组上述组织损伤明显改善。结论:MSCs移植抑制了内毒素血症小鼠的炎症反应,改善了心功能,减轻了对心脏、肝脏和肺脏的损害。 Objective:To determine the effects of bone marrow mesenchymal stem cells on mice with endotoxemia. Methods:Mice were divided into the following groups:the control group,the endotoxemia group(the LPS group),the mesenchymal stem cell treatment group(the LPS+MSCs group) and the mesenchymal stem cell group(the MSCs group). The cardiac function of mice was respectively observed at 24 hours and day 7 after LPS administration. ELISA was performed to detect the level of cytokines in the serum,and histological examinations were performed to detect morphological changes of the cardiac muscle,liver,lung and kidney. Results:Compared to the control group,serum IL-1β and TNF-α were increased in the mice of the LPS group,and MSCs treatment decreased serum IL-1β and TNF-α obviously. The cardiac function of the LPS group mice deteriorated,which was rescued by MSCs treatment.Apoptosis of cardiomyocytes and hepatocytes in the mice of the LPS group was increased. Edema was observed in the pulmonary interstitium and alveolus,and ameliorated by MSCs treatment. Conclusion:MSCs inhibit the inflammatory reaction of mice with endotoxemia,improves the cardiac function and reduces the damage of the heart,liver and lung.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2014年第7期921-925,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省科技厅基础研究计划(BK20131449)
关键词 骨髓间充质干细胞 内毒素血症 脓毒血症 组织器官损伤 bone marrow mesenchymal stem cells endotoxemia sepsis tissue and organ injury
  • 相关文献

参考文献15

  • 1Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000 [ J ].N Engl J Med,2003,348(16):1546-1554.
  • 2Marshall JC,Charbonney E,Gonzalez PD.The immune system in critical illness [J].Clin Chest Med,2008,29(4):605-616.
  • 3Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[ J ].Nature,1987,330(6149):662-664.
  • 4Ianaro A,Tersigni M,D'Acquisto F.New insight in LPS antagonist [J].Mini Rev Med Chem,2009,9(3):306-317.
  • 5Claridge JA,Enelow RI,Young JS.Hemorrhage and re-suscitation induce delayed inflammation and pulmonary dysfunction in mice [J].J Surg Res,2000,92(2):206-213.
  • 6Todorovic Z,Nesic Z,Stojanovic R,et al.Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury:it is never too late for the pretreatment [J].J Pharmacol Sci,2008,107(4):465-470.
  • 7Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Confer-ence Committee.American College of Chest Physicians/Society of Critical Care Medicine [J].Chest,1992,101(6):1644-1655.
  • 8Opal SM,Laterre PF,Francois B,et al.Effect of eritoran,an antagonist of MD2-TLRd,on mortality in patients with severe sepsis:the ACCESS randomized trial [J].JAMA,2013,309(11):1154-1162.
  • 9Hagar JA,Powell DA,Aachoui Y,et al.Cytoplasmic LPS activates easpase-ll:implieations in TLR4-independent endotoxie shock [J].Science,2013,341(6151):1250-1253.
  • 10Aggarwal S,Pittenger MF.Human mesenchymal stem cells modulate allogeneic immune cell responses [J].Blood,2005,105(4):1815-1822.

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部